Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure

Kidney International

Volumn 42, Issue 1, 1992, Pages 46-55

  Kakinuma, Yoshihiko ^a   Kawamura, Tetsuya ^a   Bills, Teresa ^a   Yoshioka, Toshimasa ^a   Ichikawa, Iekuni ^a   Fogo, Agnes ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; ANGIOTENSIN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDRALAZINE; HYDROCHLOROTHIAZIDE; LISINOPRIL; RESERPINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; GLOMERULOSCLEROSIS; HYPERTENSION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; VASCULAR LESION;

EID: 0026691041     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1992.259     Document Type: Article

References (41)

1. FOGO A, YOSHIDA Y, GLICK AD, HOMMA T, ICHIKAWA I: Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. J Clin Invest 82:322-330, 1988
2. YOSHIDA Y, KAWAMURA T, IKOMA M, FOGO A, ICHIKAWA I: Effects of antihypertensive drugs on glomerular morphology. Kindey Int 36:626-635, 1989
3. IKOMA M, KAWAMURA T, KAKINUMA Y, FOGO A, ICHIKAWA I: Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on the glomerular mesangial lesion. Kidney Int 40:195-202, 1991
4. ANDERSON S, BRENNKE HG, BRENNER BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993-2000, 1986
5. ZATZ R, DUNN BR, MEYER TW, ANDERSON S, RENNKE HG, BRENNER BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
6. ANDERSON S, RENNKE HG, GARCIA DL, BRENNER BM: Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 36:526-536, 1989
7. ANDERSON S, DIAMOND JR, KARNOVSKY MJ, BRENNER BM: Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J Clin Invest 82:1757-1768, 1988
8. BRUNNER FP, THIEL G, HEMLE M, BOCK HA, MIHATSCH MJ: Long-term enalapril and verapamil in rats with reduced renal mass. Kidney Int 36:969-977, 1989
9. ANDERSON S, MEYER TW, RENNKE HG, BRENNER BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76:612-619, 1985
10. OWENS GK: Influence of blood pressure on development of aortic medical smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension 9:178-187, 1987
11. LINZ W, SCHØLKENS BA, GANTEN D: Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens 11:1325-1350, 1989
12. CANBY CA, TOMANEK RJ: Role of lowering arterial pressure on maximal coronary flow with and without regression of cardiac hypertrophy. Am J Physiol 257:H1110-H1118, 1989
13. CLOZEL JP, KUHN H, HEFTI F: Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension. J Hypertens 7:267-275, 1989
14. WANG DH, PREWITT RL: Captopril reduces aortic and microvasular growth in hypertensive and normotensive rats. Hypertension 15:68-77, 1990
15. BRUNNER HR, KIRSHMAN JD, SEALEY JE, LARAGH JH: Hypertension of renal origin: Evidence for two different mechanisms. Science 174:1344-1346, 1971
16. AKAHOSHI M, CARRETERO OA: Body fluid volume and angiotensin II in maintenance of one-kidney, one clip hypertension. Hypertension 14:269-273, 1989
17. CLOZEL JP, KUHN H, HEFTI F: Decreases of vascular hypertrophy in four different types of arteries in spontaneously hypertensive rats. Am J Med 87(Suppl 6B):92S-95S, 1989
18. POWELL JS, CLOZEL JP, MÜLLER RKM, KUHN H, HEFTI F, HOSANG M, BAUMGARTNE HR: Inhibitions of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245:186-188, 1989
19. 1 receptor antagonist. Am J Pathol 139:1291-1296, 1991
20. RAMBAUSEK M, RITZ E, MALL G, MEHLS O, KATUS H: Myocardiac hypertrophy in rats with renal insufficiency. Kidney Int 28:775-782, 1985
21. OKEN DE: Does the ultrafiltration coefficient play a key role in regulating glomerular filtration in the rat. Am J Physiol 25:F505-F515, 1989
22. PFEFFER JM, PFEFFER MA, FRÖHLICH ED: Validity of an indirect tail-cuff method for determining systolic arterial pressure in anesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med 78:957-962, 1971
23. CUSHMAN DW, WANG FL, FUNG WC, GROVER GJ, HARVEY CM, ACALESE RJ, MITCH SL, DEFORREST JM: Comparison in vitro, ex vivo and in vivo of the action of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE). Br J Clin Pharamacol 28:115S-131S, 1989
24. CHANG RSL, SIEGL PKS, CLINESCHMIDT BV, MANTLO NB, CHAKRAVARTY PK, GREENLEE WJ, PATCHETT AA, LOTTI VJ: In vitro pharmacology of a highly potent and selective nonpeptide angiotensin II (AII) receptor antagonist: L-158,809. (abstract) FASEB J 5 (Part III):6993, 1991
25. MANTLO NB, CHAKRAVARTY PK, ONDEYKA D, CHEN A, CAMARA VJ, CHANG RSL, LOTTI VJ, SIEGL PKS, PATCHETT AA, GREENLEE WJ: Potent, orally active imidazo[4,5-b]pyridine angiotensin II receptor antagonists. J Med Chem 34:2919-2922, 1991
26. SIEGL PKS, CHANG RS, GREENLEE WJ, LOTTI VJ, MANTLO NB, PATCHETT AA, SWAET CS: In vivo pharmacology of a highly potent and selective nonpeptide angiotensin II (AII) receptor antagonist: L-158,809. (abstract) FASEB J 5 (Part III):6994, 1991
27. ICHIKAWA I, MADDOX DA, COGAN MG, BRENNER BM: Dynamics of glomerular ultrafiltration in euvolemic Munich-Wistar rats. Renal Physiol 1:121-131, 1978
28. RAIJ L, AZAR S, KEANE W: Mesangial immune injury, hypertension and progressive glomerular damage in Dahl rats. Kidney Int 26:137-143, 1984
29. FÜHR J, KAZMARCZYK J, KRÜTTGEN CD: Eine einfache colorimetrishe Methode zur Inulinbestimmung für Nieren-clearance-untersuchungen bei Stoffwechselgesunden und Diabetikern. Klin Wochenschr 33:729-730, 1955
30. WALLENSTEIN S, ZUCKER CL, FLEISS JL: Some statistical methods useful in circulation research. Circ Res 47:1-9, 1980
31. WEBER KT, JANICKI JS, PICK R, CAPASSO J. ANVERSA P: Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension. Am J Cardiol 65:1G-7G, 1990
32. LEVY BI, MICHEL JB, SALZMANN JL, AZIZI M, POITEVIN P, SAFAR M, CAMILLERI JP: Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ Res 63:227-239, 1988
33. RYAN JW, RYAN US, SCHULTZ DR, WHITAKER C, CHUNG A, DORER FE: Subcellular localization of pulmonary angiotensin converting enzyme (kininase II). Biochem J 146:497-499, 1975
34. CALDWELL PRB, SEEGAL BC, HSU KC: Angiotensin converting enzyme: Vascular endothelial 1 localization. Science 191:1050-1051, 1976
35. ODY C, JUNOD AF: Converting enzyme activity in endothelial cells isolated from pig pulmonary artery and aorta. Am J Physiol 232:C95-C98, 1977
36. MIYAZAKI M, OKUNISHI H, NISHIMURA K, TODA N: Vascular angiotensin converting enzyme activity in man and other species. Clin Sci 66:39-45, 1984
37. DZAU VJ, GIBBONS GH: Autocrine-paracrine mechanisms of vascular myocytes in systemic hypertension. Am J Cardiol 60:991-1031, 1987
38. RE RN: Cellular mechanisms of growth in cardiovascular tissue. Am J Cardiol 60:1041-1091, 1987
39. SEIKALY MG, ARANT BS JR, SENEY FD JR: Endogenous angiotensin concentrations in specific intrarenal compartments of the rat. J Clin Invest 86:1352-1357, 1990
40. HOMMA T, HOOVER RL, ICHIKAWA I, HARRIS RC: Angiotensin II induces hypertrophy and stimulates collagen production in cultured rat mesangial cell. (abstract) Clin Res 38:358A, 1990
41. TAUBMAN MB, BERK BC, IZUMO S, TSUDA T, ALEXANDER RW, NADAL-GINARD B: Angiotensin II induces c-fos mRNA in aortic smooth muscle. J Biol Chem 264:526-530, 1989